2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-44868
    5-Methyl-3-methylenehexan-2-one
    5-Methyl-3-methylenehexan-2-one is a drug intermediate for synthesis of various active compounds.
    5-Methyl-3-methylenehexan-2-one
  • HY-32865
    tert-Butyl 2,2,2-trichloroacetimidate
    tert-Butyl 2,2,2-trichloroacetimidate is a tert-butylation reagent. tert-Butyl 2,2,2-trichloroacetimidate achieves mild, nonreversible tert-butylation of alcohols and phenols. tert-Butyl 2,2,2-trichloroacetimidate is used in the synthesis of antimicrobial agents.
    tert-Butyl 2,2,2-trichloroacetimidate
  • HY-W440527
    (4-Cyclopropyl-6-methoxypyrimidin-5-yl)boronic acid
    		99.94%
    (4-Cyclopropyl-6-methoxypyrimidin-5-yl)boronic acid is a drug intermediate for synthesis of various active compounds.
    (4-Cyclopropyl-6-methoxypyrimidin-5-yl)boronic acid
  • HY-W105804
    Selenocystamine dihydrochloride
    		99.63%
    Selenocystamine dihydrochloride is a selenocysteine derivative that can be used in the synthesis of other active compounds. Selenocystamine dihydrochloride can also induce the aggregation of amphiphilic p-sulfonatocalixarene to form supramolecular nanoparticles.
    Selenocystamine dihydrochloride
  • HY-W001996
    6-Hydroxynicotinic acid
    		99.83%
    6-Hydroxynicotinic acid is an intermediate in the oxidation of Nicotinic acid (HY-B0143) by Pseudomonas fluorescens and metabolite. 6-Hydroxynicotinic acid can be isolated from root exudates of Cucumis melo. 6-Hydroxynicotinic acid disrupts the Auxin signaling pathway. 6-Hydroxynicotinic acid inhibits haustoria precursor formation in Phlipanche aegyptiaca.
    6-Hydroxynicotinic acid
  • HY-76387
    rel-(2R,3S)-1,2,3,4-Tetrahydro-1,4-methanonaphthalene-2,3-diol
    		99.81%
    rel-(2R,3S)-1,2,3,4-Tetrahydro-1,4-methanonaphthalene-2,3-diol is a drug intermediate for synthesis of various active compounds.
    rel-(2R,3S)-1,2,3,4-Tetrahydro-1,4-methanonaphthalene-2,3-diol
  • HY-Y0975
    Silver(I) fluoride
    		99.90%
    Silver(I) fluoride is a drug intermediate for synthesis of various active compounds.
    Silver(I) fluoride
  • HY-47848
    1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide
    		99.74%
    1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide is a drug intermediate for synthesis of various active compounds.
    1-Benzyl-4-hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-6-carboxamide
  • HY-W003625
    2-Cyanothiazole
    2-Cyanothiazole is a drug intermediate for synthesis of various active compounds.
    2-Cyanothiazole
  • HY-101541
    Docosahexaenoic acid methyl ester
    Docosahexaenoic Acid methyl ester is a methylated docosahexaenoic acid analog which can be intercalated into membrane phospholipids without being oxidized or hydrolyzed.
    Docosahexaenoic acid methyl ester
  • HY-W015796
    3-Methyl-5-nitropyridine
    3-Methyl-5-nitropyridine is a drug intermediate for synthesis of various active compounds.
    3-Methyl-5-nitropyridine
  • HY-I0016
    (s)-2-Amino-5-methoxytetralin hydrochloride
    		99.98%
    (s)-2-Amino-5-methoxytetralin hydrochloride is a drug intermediate for synthesis of various active compounds.
    (s)-2-Amino-5-methoxytetralin hydrochloride
  • HY-78184
    1-Boc-3-benzyl-3-piperidinecarboxylic acid
    		99.96%
    1-Boc-3-benzyl-3-piperidinecarboxylic acid is a drug intermediate for synthesis of various active compounds.
    1-Boc-3-benzyl-3-piperidinecarboxylic acid
  • HY-W017542
    L-Pyrohomoglutamic acid
    L-Pyrohomoglutamic acid is an amino acid building block. L-Pyrohomoglutamic acid can be used to synthesize ligands for FK506-binding proteins (FKBPs) and histone deacetylase (HDAC) inhibitors.
    L-Pyrohomoglutamic acid
  • HY-78855
    2-(Hydroxy(4-phenoxyphenyl)methylene)malononitrile
    2-(Hydroxy(4-phenoxyphenyl)methylene)malononitrile is a drug intermediate for synthesis of various active compounds.
    2-(Hydroxy(4-phenoxyphenyl)methylene)malononitrile
  • HY-W145437
    4-[(Trans-4-aminocyclohexyl)oxy]-2-chloro-Benzonitrile hydrochloride
    4-[(Trans-4-aminocyclohexyl)oxy]-2-chloro-Benzonitrile hydrochloride is a drug intermediate for synthesis of various active compounds.
    4-[(Trans-4-aminocyclohexyl)oxy]-2-chloro-Benzonitrile hydrochloride
  • HY-153891
    Deruxtecan 2-hydroxypropanamide
    		99.69%
    Deruxtecan 2-hydroxypropanamide is a highly stable Deruxtecan (HY-13631E) analog that specifically binds to receptors highly expressed in tumor cells.
    Deruxtecan 2-hydroxypropanamide
  • HY-W016480
    4-Amino-L-phenylalanine
    		99.98%
    4-Amino-L-phenylalanine is a metabolic intermediate. 4-Amino-L-phenylalanine can be used in the production of Chloramphenicol (HY-B0239) and Pristinamycin I in Streptomyces venezuelae and S. pristinaespiralis, respectively.
    4-Amino-L-phenylalanine
  • HY-Y0989
    Acetophenone
    		99.84%
    Acetophenone (1-Phenylethan-1-One) is an organic compound with simple structure. Acetophenone can be bioreduced to phenylethanol (PEA).
    Acetophenone
  • HY-W040233B
    L-Lactic acid (sodium) (purity≥90%)
    		98.0%
    Sodium (S)-2-hydroxypropanoate (Sodium L-lactate) (purity≥90%) is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid.
    L-Lactic acid (sodium) (purity≥90%)